Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2008 Apr 30:6:31.
doi: 10.1186/1477-7525-6-31.

The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials

Michael Shaw  1 , John Dent, Timothy Beebe, Ola Junghard, Ingela Wiklund, Tore Lind, Folke Johnsson
Affiliations
Randomized Controlled Trial

The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials

Michael Shaw et al. Health Qual Life Outcomes. .

Abstract

Background: Critical needs for treatment trials in gastroesophageal reflux disease (GERD) include assessing response to treatment, evaluating symptom severity, and translation of symptom questionnaires into multiple languages. We evaluated the previously validated Reflux Disease Questionnaire (RDQ) for internal consistency, reliability, responsiveness to change during treatment and the concordance between RDQ and specialty physician assessment of symptom severity, after translation into Swedish and Norwegian.

Methods: Performance of the RDQ after translation into Swedish and Norwegian was evaluated in 439 patients with presumed GERD in a randomized, double-blind trial of active treatment with a proton pump inhibitor.

Results: The responsiveness was excellent across three RDQ indicators. Mean change scores in patients on active treatment were large, also reflected in effect sizes that ranged from a low of 1.05 (dyspepsia) to a high of 2.05 (heartburn) and standardized response means 0.99 (dyspepsia) and 1.52 (heartburn). A good positive correlation between physician severity ratings and RDQ scale scores was seen. The internal consistency reliability using alpha coefficients of the scales, regardless of language, ranged from 0.67 to 0.89.

Conclusion: The results provide strong evidence that the RDQ is amenable to translation and represents a viable instrument for assessing response to treatment, and symptom severity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Responsiveness of GERD Score.
See this image and copyright information in PMC

References

    1. Dent J, Armstrong D, Delaney B, Moayyedi P, Talley NJ, Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut. 2004;53:iv1–24. doi: 10.1136/gut.2003.034272. - DOI - PMC - PubMed
    1. U.S. Department of Health and Human Services, Food and Drug Administration Guidance for Industry. Patient reported outcome measures: use in medical product development to support labeling claims. 2006. http://www.fda.gov/cder/guidance/5460dft.pdf (accessed 21 January 2008). - PMC - PubMed
    1. Shaw M, Talley NJ, Beebe T, Rockwood T, Carlsson R, Adlis S, Fendrick AM, Jones R, Dent J, Bytzer P. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol. 2001;96:52–57. doi: 10.1111/j.1572-0241.2001.03451.x. - DOI - PubMed
    1. Johnsson F, Hatlebakk JG, Klintenberg AC, Román J, Toth E, Stubberöd A, Falk A, Edin R. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease. Scand J Gastroenterol. 2003;38:354–359. doi: 10.1080/00365520310002139. - DOI - PubMed
    1. Johnsson F, Hatlebakk JG, Klintenberg AC, Román J. Symptom-relieving effect of esomeprazole 40 mg daily in patients with heartburn. Scand J Gastroenterol. 2003;38:347–353. doi: 10.1080/00365520310002157. - DOI - PubMed